TNFRSF10B and hepatocellular carcinoma: Glycoproteomic analysis showed that the glycosylated residues of death receptor 5 (DR5) in the “TT” patient-derived HCC tissues were clustered in the two major glycosylation sites, in contrast to a scattered glycosylation pattern in the “non-TT” liver tumor tissues.